On Predicting lung cancer subtypes using 'omic' data from tumor and tumor-adjacent histologically-normal tissue von Pineda, Arturo López, Ogoe, Henry Ato, Balasubramanian, Jeya Balaji, Rangel Escareño, Claudia, Visweswaran, Shyam, Herman, James Gordon, Gopalakrishnan, Vanathi

Volltext

The new archery ; hobby, sport, and craft / by Paul H. Gordon; drawings by Andrew R. Janson von Gordon, Paul Herman, 1902

Volltext bestellen

Acetylcholine receptors are required for postsynaptic aggregation driven by the agrin signalling pathway von Grow, Wade A., Gordon, Herman

Volltext

A Mechanism for Acetylcholine Receptor Clustering Distinct from Agrin Signaling von Grow, Wade A., Ferns, Michael, Gordon, Herman

Volltext

Negative control of the helix-loop-helix family of myogenic regulators in the NFB mutant von Peterson, Charlotte A., Gordon, Herman, Hall, Zach W., Paterson, Bruce M., Blau, Helen M.

Volltext

GPX3 as a predictive biomarker in gastrointestinal malignancies von Pelosof, Lorraine Cheryl, Yerram, Sashidhar R., Yanagisawa, Breann, Azad, Nilofer Saba, Herman, James Gordon

Volltext

L‐type calcium channels mediate acetylcholine receptor aggregation on cultured muscle von Milholland, Rebecca B.R., Dulla, Christopher, Gordon, Herman

Volltext

Prolonged Cytosolic Calcium Elevations in Growth Cones Contacting Muscle von Graf, Robert A., Kater, Stanley B., Gordon, Herman

Volltext

Novel score to predict outcome in resected pancreatic neuroendocrine tumors (pNET) von Viudez, Antonio, Laheru, Daniel A., Stark, Alejandro, Azad, Nilofer Saba, Wolfgang, Christopher Lee, Baylin, Stephen, Herman, James Gordon, Maleki, Zahra, De Jesus-Acosta, Ana

Volltext

A role for acetylcholine receptors in their own aggregation on muscle cells von Milholland, Rebecca B.R., Gordon, Herman

Volltext

A new immunohistochemistry prognostic score (IPS) for recurrence and survival in pancreatic neuroendocrine tumors (PanNET) von Viudez, Antonio, Carvalho, Filipe LF, Maleki, Zahra, Zahurak, Marianna, Laheru, Daniel A., Stark, Alejandro, Azad, Nilofer Saba, Wolfgang, Christopher Lee, Baylin, Stephen, Herman, James Gordon, De Jesus-Acosta, Ana

Volltext

Epigenetic Therapeutics and Their Impact in Immunotherapy of Lung Cancer von Cho, Ju Hwan, Oezkan, Filiz, Koenig, Michael, Otterson, Gregory A., Herman, James Gordon, He, Kai

Volltext

An interim analysis of a phase II study using an epigenetic biomarker (CHFR methylation status) to personalize chemotherapy in patients with operable esophageal cancer von Kelly, Ronan Joseph, Wrangle, John, Hales, Russell K., Molena, Daniela, Yang, Stephen C., Rodgers, Kristen, Lang, Margaret, Reynolds, Jeffrey, Beckman, Tammy, Choflet, Amanda, Brock, Malcolm, Herman, James Gordon

Volltext

Some aspects of metropolitan road and rail transit. Lecture by Henry Herman Gordon ... With a report of the discussion von Gordon, Henry Herman

Volltext bestellen

Phase 2 study investigating the safety, efficacy, and surrogate biomarkers of response to 5-azacitidine (5-AZA) and entinostat in advanced breast cancer von Connolly, Roisin M., Jankowitz, Rachel Catherine, Zahnow, Cynthia A., Zhang, Zhe, Rudek, Michelle A., Slater, Shannon, Powers, Penny, Jeter, Stacie, Brufsky, Adam, Piekarz, Richard, Herman, James Gordon, Ahuja, Nita, Somlo, George, Garcia, Agustin A., Baylin, Stephen, Davidson, Nancy E., Stearns, Vered

Volltext

Blood-based screening for methylation changes in colorectal cancer patients using novel nanotechnologies von Ahuja, Nita, Kwak, Ruby, Keeley, Brian, Stark, Alejandro, Guzzetta, Angela Anna, Wolfgang, Christopher Lee, Herman, James Gordon, Iacobuzio-Donahue, Christine A, Wang, Tza Huei

Volltext

Using CHFR expression to predict response and survival after first line treatment with carboplatin-paclitaxel in NSCLC von Pillai, Rathi Narayana, Brodie, Seth Aaron, Li, Ge, Herman, James Gordon, Brock, Malcolm, Owonikoko, Taofeek Kunle, Ramalingam, Suresh S., Khuri, Fadlo Raja, Brandes, Johann Christoph

Volltext

A phase II study of combination epigenetic therapy in metastatic colorectal cancer (mCRC): A phase II consortium (P2C)/Stand Up 2 Cancer (SU2C) study von Azad, Nilofer Saba, El-Khoueiry, Anthony B., Mahoney, Michelle R., Adkins, Douglas, Flynn, Patrick J., Bahary, Nathan, Kim, George P., Pitot, Henry Clement, Erlichman, Charles, Donehower, Ross C., Herman, James Gordon, Baylin, Stephen, Ahuja, Nita

Volltext

CHFR promoter methylation indicates poor prognosis in stage II microsatellite stable colorectal cancer von van Engeland, Manon, Cleven, Arjen, Derks, Sarah, Draht, Muriel XG, Smits, Kim M, Melotte, Veerle, Weijenberg, Matty P, Herman, James Gordon, de Bruïne, Adriaan P, Van Criekinge, Wim

Volltext

Predicting sensitivity to azacytidine in non-small cell cancer lines by absence of activating mutations von Wrangle, John, Mohammad, Helai P, Abukhdeir, Abde, Juergens, Rosalyn A., Harbom, Kirsten, Rodgers, Kristen, Shin, James, Zahnow, Cynthia A., Baylin, Stephen, Herman, James Gordon, Rudin, Charles M., Brock, Malcolm

Volltext